ventricular myosins

Preferred Label : ventricular myosins;

MeSH definition : Isoforms of MYOSIN TYPE II, specifically found in the ventricular muscle of the HEART. Defects in the genes encoding ventricular myosins result in FAMILIAL HYPERTROPHIC CARDIOMYOPATHY.;

MeSH synonym : isomyosins, ventricular; ventricular isomyosins; myosins, ventricular; ventricular myosin; myosin, ventricular;

MeSH hyponym : ventricular alpha-Myosin; ventricular alpha, beta- myosin; ventricular beta-Myosin; Ventricular alpha Myosin; alpha-Myosin, Ventricular; Myosin V1; Ventricular Cardiac alpha-Myosin; Cardiac alpha-Myosin, Ventricular; Ventricular Cardiac alpha Myosin; alpha-Myosin, Ventricular Cardiac; alpha-Myosin; alpha Myosin; Cardiac alpha-Myosin; Cardiac alpha Myosin; alpha-Myosin, Cardiac; Ventricular alpha, beta Myosin; Myosin V2; Ventricular beta Myosin; beta-Myosin, Ventricular; beta-Myosin; beta Myosin; Ventricular Cardiac beta-Myosin; Cardiac beta-Myosin, Ventricular; Ventricular Cardiac beta Myosin; beta-Myosin, Ventricular Cardiac; Myosin V3; Cardiac beta-Myosin; Cardiac beta Myosin; beta-Myosin, Cardiac;

MeSH Related Number : ventricular alpha-Myosin; ventricular alpha, beta- myosin; ventricular beta-Myosin;

Registry Number MeSH : EC 3.6.1.-;

Related CAS MeSH : EC 3.6.1.- (Ventricular alpha-Myosin); EC 3.6.1.- (Ventricular alpha, beta- myosin); EC 3.6.1.- (Ventricular beta-Myosin);

MeSH annotation : do not confuse X refs MYOSIN V1 and MYOSIN V3 with MYOSIN TYPE V; do not confuse entry terms MYOSIN V1, and MYOSIN V3 with MYOSIN TYPE V;

Is substance : O;

Details

Origin ID

D024723;

UMLS CUI

C0949657;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Fanconi Anemia Group J Protein [NCIt concept]
- Fanconi Anemia Group M Protein [NCIt concept]
- General Transcription and DNA Repair Factor IIH Helicase Subunit XPD [NCIt concept]
- RNA Helicase [NCIt concept]
- TFIIH Basal Transcription Factor Complex Helicase XPB Subunit [NCIt concept]
Record concept(s)
- ventricular alpha, beta- myosin [MeSH concept]
- ventricular alpha-Myosin [MeSH concept]
- ventricular beta-Myosin [MeSH concept]
- ventricular myosins [MeSH concept]
See also
- cardiomyopathy, hypertrophic, familial [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients